Browse by Section 100 Item List

Highly Specialised Drugs Program (Private Hospital)

For Pharmaceutical Benefits Scheme (PBS) Highly Specialised Drugs prescribed through private hospitals, claiming and approval of authority prescriptions is administered by Services Australia. Highly Specialised Drugs prescribed in private hospitals are Authority Required items. Application for authorisation can be made by either:

  • posting an Authority Prescription form and other application form(s), where applicable to Services Australia
  • using the form upload facility in Health Professional Online Services (HPOS)
  • using the Online PBS Authorities system (see www.servicesaustralia.gov.au/HPOS)
  • using the Services Australia free-call service for PBS Complex Drugs Programs enquiries (1800 700 270) or
  • using the appropriate Streamlined code.

Prescribers must quote the provider number of the hospital when applying. Maximum quantities and repeats for Highly Specialised Drugs are listed in the PBS Schedule. Authority approvals are required for prescriptions where the dose is above the determined maximum quantity and/or number of repeats.

Private hospital prescriptions for Highly Specialised Drugs can be dispensed by an approved private hospital dispensary or by a community pharmacy. A patient will be required to pay a contribution for each supply of a highly specialised drug at the same rate as the PBS.

The remuneration rates for Highly Specialised Drugs prescribed through private hospitals comprise the normal PBS ready-prepared dispensing fee plus a mark-up ascertained as follows:

  • 10% for drugs with an ex-manufacturer price of less than $40
  • $4 for drugs with an ex-manufacturer price of between $40 and $100
  • 4% for drugs with an ex-manufacturer price of between $100.01 and $1000
  • $40 for drugs with an ex-manufacturer price of greater than $1000.

Reciprocal Health Care Agreement – Where a patient is entitled to be treated as an eligible person as a visitor from a country with which Australia has entered into a Reciprocal Health Care Agreement, the supply will be limited to the original prescription only. Repeat prescriptions for these patients are not permitted.

  • Legend
  • MPMedical Practitioner
Prescriber code Item code Name, manner of administration and form & strength Max qty
packs
Max qty
units
No. of
repeats
MP 10182X ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 0
MP 10192K ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 4
MP 10194M ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 5
MP 12864C ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 1 1 0
MP 12896R ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 8 8 0
MP 12899X ECULIZUMABeculizumab 300 mg/30 mL injection, 30 mL vial 6 6 5
MP 12938Y ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 100 mg + tezacaftor 50 mg + ivacaftor 75 mg tablet [56] (&) ivacaftor 150 mg tablet [28], 84 1 1 5
MP 13266F ELEXACAFTOR + TEZACAFTOR + IVACAFTOR (&) IVACAFTORelexacaftor 50 mg + tezacaftor 25 mg + ivacaftor 37.5 mg tablet [56] (&) ivacaftor 75 mg tablet [28], 84 1 1 5
MP 5827Q ELTROMBOPAGeltrombopag 25 mg tablet, 28 1 28 5
MP 5828R ELTROMBOPAGeltrombopag 50 mg tablet, 28 1 28 5
MP 6251B EPOETIN ALFAepoetin alfa 1000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 6207Q EPOETIN ALFAepoetin alfa 10 000 units/mL injection, 6 x 1 mL syringes 2 12 5
MP 6204M EPOETIN ALFAepoetin alfa 2000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 6434P EPOETIN ALFAepoetin alfa 20 000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 6205N EPOETIN ALFAepoetin alfa 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 6206P EPOETIN ALFAepoetin alfa 4000 units/0.4 mL injection, 6 x 0.4 mL syringes 2 12 5
MP 6339P EPOETIN ALFAepoetin alfa 40 000 units/mL injection, 1 mL syringe 2 2 5
MP 6302Q EPOETIN ALFAepoetin alfa 5000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 6303R EPOETIN ALFAepoetin alfa 6000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MP 6305W EPOETIN ALFAepoetin alfa 8000 units/0.8 mL injection, 6 x 0.8 mL syringes 2 12 5
MP 6485H EPOETIN BETAepoetin beta 10 000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MP 6480C EPOETIN BETAepoetin beta 2000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 6481D EPOETIN BETAepoetin beta 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 6482E EPOETIN BETAepoetin beta 4000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 6483F EPOETIN BETAepoetin beta 5000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 6484G EPOETIN BETAepoetin beta 6000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 9685R EPOETIN LAMBDAepoetin lambda 1000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 9595B EPOETIN LAMBDAepoetin lambda 10 000 units/mL injection, 6 x 1 mL syringes 2 12 5
MP 9686T EPOETIN LAMBDAepoetin lambda 2000 units/mL injection, 6 x 1 mL syringes 2 12 5
MP 9687W EPOETIN LAMBDAepoetin lambda 3000 units/0.3 mL injection, 6 x 0.3 mL syringes 2 12 5
MP 9688X EPOETIN LAMBDAepoetin lambda 4000 units/0.4 mL injection, 6 x 0.4 mL syringes 2 12 5
MP 9588P EPOETIN LAMBDAepoetin lambda 5000 units/0.5 mL injection, 6 x 0.5 mL syringes 2 12 5
MP 9590R EPOETIN LAMBDAepoetin lambda 6000 units/0.6 mL injection, 6 x 0.6 mL syringes 2 12 5
MP 9593X EPOETIN LAMBDAepoetin lambda 8000 units/0.8 mL injection, 6 x 0.8 mL syringes 2 12 5
MP 11082G EPOPROSTENOLepoprostenol 1.5 mg injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack 30 30 5
MP 11069N EPOPROSTENOLepoprostenol 500 microgram injection [1 vial] (&) inert substance diluent [2 x 50 mL vials], 1 pack 30 30 5
MP 10129D EPOPROSTENOLepoprostenol 1.5 mg injection, 1 vial 30 30 5
MP 10111E EPOPROSTENOLepoprostenol 500 microgram injection, 1 vial 30 30 5
MP 13332Q ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes 1 1 5
MP 9615C ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL syringes 1 1 0
MP 13326J ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices 1 1 5
MP 9641K ETANERCEPTetanercept 50 mg/mL injection, 4 x 1 mL pen devices 1 1 0
MP 13295R ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack 2 2 5
MP 6367D ETANERCEPTetanercept 25 mg injection [4 vials] (&) inert substance diluent [4 x 1 mL syringes], 1 pack 1 1 0
MP 6459Y EVEROLIMUSeverolimus 250 microgram tablet, 60 2 120 5
MP 6460B EVEROLIMUSeverolimus 500 microgram tablet, 60 2 120 5
MP 6461C EVEROLIMUSeverolimus 750 microgram tablet, 60 4 240 5
MP 9582H EVEROLIMUSeverolimus 1 mg tablet, 60 4 240 5